Howard Hughes Medical Institute’s Henry Schein HSIC Stock Holding History

Howard Hughes Medical Institute’s Portfolio HSIC Stock Details HSIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22	Closed	-$1.66K	–	249
2025 Q4	$1.66K	Sell	22 -1	-4%	-$70	﹤0.01%	484
2025 Q3	$1.53K	Sell	23 -3	-12%	-$208	﹤0.01%	491
2025 Q2	$1.9K	Buy	+26	New	+$1.79K	﹤0.01%	470

Other funds holding HSIC

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Howard Hughes Medical Institute's HSIC Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Henry Schein (HSIC) in Q1 2026, closing a stake of 22 shares — an estimated $1.66K sold.

Howard Hughes Medical Institute first reported a position in HSIC in Q2 2025 and held it in 3 quarters. The position peaked at $1.9K in Q2 2025. 558 funds tracked by Wall St. Rank hold HSIC as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Henry Schein position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 22 Henry Schein shares in Q1 2026, an estimated $1.66K.
Howard Hughes Medical Institute first reported a position in Henry Schein in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's Henry Schein position peaked at $1.9K in Q2 2025.
558 funds tracked by Wall St. Rank held Henry Schein as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.